EasySep™小鼠TIL（CD45）正选试剂盒
搜索结果: 'methocult media formulations for human hematopoietic cells serum containing'
-
Re-Creating Disease with Kidney Organoids and CRISPR In this webinar, Dr. Benjamin Freedman from the University of Washington provides an overview of re-creating disease using kidney organoids and CRISPR-Cas9 genome editing. As a postdoctoral fellow in the Renal Division at Brigham and Women’s Hospital at Harvard Medical School, Dr. Freedman was responsible for several innovative techniques that he describes in this webinar, including differentiation of human pluripotent stem cells (hPSCs) into kidney organoids containing nephron-like segments and generating knockout mutations in organoids with CRISPR. -
“Manipulating Stem Cell Fate” Featuring Dr. Shuibing Chen On this episode of the Stem Cell Podcast, Dr. Shuibing Chen from Weill Cornell Medicine talks about using organoids to study diabetes, Zika, and SARS-CoV-2. -
Cell-Reprogramming Technology and Neuroscience Details on human iPSC-derived models of neuropsychiatric and neurodegenerative disorders -
STEMdiff™ Kits for Robust and Efficient Differentiation of hPSCs to Multiple Cell Types Dr. Melanie Kardel, scientist at STEMCELL Technologies, describes the use of STEMdiff™ kits to differentiate human pluripotent stem cells to all three germ layers. This video was filmed during the Innovation Showcase at ISSCR 2016 in San Francisco.
